The Experts below are selected from a list of 669 Experts worldwide ranked by ideXlab platform
Robert W Thompson - One of the best experts on this subject based on the ideXlab platform.
-
associations between clinical diagnostic criteria and pretreatment patient reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndrome
Journal of Vascular Surgery, 2017Co-Authors: Joshua Balderman, Katherine M Holzem, Beverly J Field, Michael M Bottros, Ahmmad A Abuirqeba, Chandu Vemuri, Robert W ThompsonAbstract:Abstract Objective Neurogenic thoracic outlet syndrome (NTOS) is caused by dynamic compression of the brachial plexus at the level of the supraclavicular scalene triangle or the subcoracoid (pectoralis minor) space, or both. The purpose of this study was to characterize relationships between 14 clinical diagnostic criteria (CDC) and seven pretreatment patient-reported outcomes measures (PROMs) in a prospective cohort of patients with NTOS. Methods There were 183 new patient referrals between July 1 and December 31, 2015, with 150 (82%) meeting an established set of predefined CDC for NTOS. PROMs were evaluated across five domains: pain severity, functional disability, depression, quality of life, and pain catastrophizing. Linear regression and Pearson correlation statistics were used to analyze associations between CDC and PROMs. Results Mean ± standard error patient age was 37.1 ± 1.1 years (range, 12-66 years), and 107 (71%) were women. Five (3%) had a cervical rib, and 15 (10%) had recurrent NTOS. The most frequently positive CDC were neck or upper extremity pain (99%), upper extremity or Hand Paresthesia (94%), symptom exacerbation by arm elevation (97%), localized supraclavicular or subcoracoid tenderness to palpation (96%), and a positive 3-minute elevated arm stress test (94%; mean duration, 102.0 ± 5.1 seconds). The number of positive CDC (mean, 9.6 ± 0.1) correlated with the degree of tenderness to palpation and the duration of elevated arm stress test, as well as with PROMs for pain severity, functional disability, depression, physical quality of life, and pain catastrophizing (all P P Conclusions This study illustrates the relative strengths of 14 CDC and seven PROMs to evaluate patients with NTOS, helping validate the selected CDC and highlighting the potential role of pain catastrophizing in functional disability. This cohort will provide valuable information on the utility of different CDC and PROMs to predict treatment outcomes.
Byoungwoo Kim - One of the best experts on this subject based on the ideXlab platform.
-
clinical analysis about treatment of myofascial pain syndrome mps with sweet bee venom on Hand Paresthesia based on thoracic outlet syndrome
Journal of Pharmacopuncture, 2010Co-Authors: Byoungwoo Kim, Hye Chul Yoon, Jae Seuk Park, Kirok KwonAbstract:Objectives: The objective of this study was to compare the effects of Sweet Bee Venom(Sweet BV) Therapy between the Hand Paresthesia patients with Osteoporosis and without Osteoporosis. Methods: This study was carried out to established the clinical criteria of Hand parethesia. The patients who had past history of diabeics, neuropathy induced by alcohol or drug and was positive on Myofacial Pain Syndrome Theory were excluded. 32 patients who had Hand Paresthesia related with unknown-reason was selected by the interview process. And the effects of treatment were analyzed using VAS score before treatment, after treatment, after 1 month and after 3 months. Results and conclusion: After treatment, While Osteoporosis group decrease from 64.81±17.81 to 27.21±17.32, Non-Osteoporosis group decrease from 58.76±11.43 to 24.74±13.81 by VAS scores. and After 3 months, While Osteoporosis group increase from 27.21±17.32 to 54.96±19.40, NonOsteoporosis group increase from 24.74±13.81 to 32.43±15.57. Non-Osteoporosis group was accordingly more effective than Osteoporosis group after 3 months. So Sweet BV therapy for Hand numbness patients without Osteoporosis was effective than patients with Osteoporosis.
-
clinical analysis about diagnosis and treatment of 86 Hand Paresthesia cases using mps theory and pharmacopuncture therapy
Journal of Pharmacopuncture, 2007Co-Authors: Jongjin Jeong, Sooyeon Kim, Insun Han, Hyunmin Kang, Kirok Kwon, Byoungwoo KimAbstract:Objectives Hand Paresthesia is common syndrome and the cause is more unknown than known reason. The Purpose of this study were investigated the effects of Myofacial Pain Syndrome theory to make diagnosis and treatment by Pharmacopuncture for the patients of Hand Paresthesia. Method This study was carried out to established the clinical criteria of Hand parethesia. The patients who had past history of diabeics, neuropathy induced by alcohol or drug were excluded, and 86 patients who had Hand Paresthesia related with unknown-reason was selected by the interview process. And the effects of Pharmacopuncture theory were analyzed using VAS score before and after treatment. Results and conclusions 56.9% of unknown-reason patients are positive at diagnosis by MPS theory. While positive group decrease from to , negative group decrease from to by VAS scores. Positive group was accordingly more effective than negative group. So diagnosis and treatment for Hand numbness patients by MPS theory was useful in clinical.
Kirok Kwon - One of the best experts on this subject based on the ideXlab platform.
-
clinical analysis about treatment of myofascial pain syndrome mps with sweet bee venom on Hand Paresthesia based on thoracic outlet syndrome
Journal of Pharmacopuncture, 2010Co-Authors: Byoungwoo Kim, Hye Chul Yoon, Jae Seuk Park, Kirok KwonAbstract:Objectives: The objective of this study was to compare the effects of Sweet Bee Venom(Sweet BV) Therapy between the Hand Paresthesia patients with Osteoporosis and without Osteoporosis. Methods: This study was carried out to established the clinical criteria of Hand parethesia. The patients who had past history of diabeics, neuropathy induced by alcohol or drug and was positive on Myofacial Pain Syndrome Theory were excluded. 32 patients who had Hand Paresthesia related with unknown-reason was selected by the interview process. And the effects of treatment were analyzed using VAS score before treatment, after treatment, after 1 month and after 3 months. Results and conclusion: After treatment, While Osteoporosis group decrease from 64.81±17.81 to 27.21±17.32, Non-Osteoporosis group decrease from 58.76±11.43 to 24.74±13.81 by VAS scores. and After 3 months, While Osteoporosis group increase from 27.21±17.32 to 54.96±19.40, NonOsteoporosis group increase from 24.74±13.81 to 32.43±15.57. Non-Osteoporosis group was accordingly more effective than Osteoporosis group after 3 months. So Sweet BV therapy for Hand numbness patients without Osteoporosis was effective than patients with Osteoporosis.
-
clinical analysis about diagnosis and treatment of 86 Hand Paresthesia cases using mps theory and pharmacopuncture therapy
Journal of Pharmacopuncture, 2007Co-Authors: Jongjin Jeong, Sooyeon Kim, Insun Han, Hyunmin Kang, Kirok Kwon, Byoungwoo KimAbstract:Objectives Hand Paresthesia is common syndrome and the cause is more unknown than known reason. The Purpose of this study were investigated the effects of Myofacial Pain Syndrome theory to make diagnosis and treatment by Pharmacopuncture for the patients of Hand Paresthesia. Method This study was carried out to established the clinical criteria of Hand parethesia. The patients who had past history of diabeics, neuropathy induced by alcohol or drug were excluded, and 86 patients who had Hand Paresthesia related with unknown-reason was selected by the interview process. And the effects of Pharmacopuncture theory were analyzed using VAS score before and after treatment. Results and conclusions 56.9% of unknown-reason patients are positive at diagnosis by MPS theory. While positive group decrease from to , negative group decrease from to by VAS scores. Positive group was accordingly more effective than negative group. So diagnosis and treatment for Hand numbness patients by MPS theory was useful in clinical.
Joshua Balderman - One of the best experts on this subject based on the ideXlab platform.
-
associations between clinical diagnostic criteria and pretreatment patient reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndrome
Journal of Vascular Surgery, 2017Co-Authors: Joshua Balderman, Katherine M Holzem, Beverly J Field, Michael M Bottros, Ahmmad A Abuirqeba, Chandu Vemuri, Robert W ThompsonAbstract:Abstract Objective Neurogenic thoracic outlet syndrome (NTOS) is caused by dynamic compression of the brachial plexus at the level of the supraclavicular scalene triangle or the subcoracoid (pectoralis minor) space, or both. The purpose of this study was to characterize relationships between 14 clinical diagnostic criteria (CDC) and seven pretreatment patient-reported outcomes measures (PROMs) in a prospective cohort of patients with NTOS. Methods There were 183 new patient referrals between July 1 and December 31, 2015, with 150 (82%) meeting an established set of predefined CDC for NTOS. PROMs were evaluated across five domains: pain severity, functional disability, depression, quality of life, and pain catastrophizing. Linear regression and Pearson correlation statistics were used to analyze associations between CDC and PROMs. Results Mean ± standard error patient age was 37.1 ± 1.1 years (range, 12-66 years), and 107 (71%) were women. Five (3%) had a cervical rib, and 15 (10%) had recurrent NTOS. The most frequently positive CDC were neck or upper extremity pain (99%), upper extremity or Hand Paresthesia (94%), symptom exacerbation by arm elevation (97%), localized supraclavicular or subcoracoid tenderness to palpation (96%), and a positive 3-minute elevated arm stress test (94%; mean duration, 102.0 ± 5.1 seconds). The number of positive CDC (mean, 9.6 ± 0.1) correlated with the degree of tenderness to palpation and the duration of elevated arm stress test, as well as with PROMs for pain severity, functional disability, depression, physical quality of life, and pain catastrophizing (all P P Conclusions This study illustrates the relative strengths of 14 CDC and seven PROMs to evaluate patients with NTOS, helping validate the selected CDC and highlighting the potential role of pain catastrophizing in functional disability. This cohort will provide valuable information on the utility of different CDC and PROMs to predict treatment outcomes.
Stefano Tamburin - One of the best experts on this subject based on the ideXlab platform.
-
proximal pain in patients with carpal tunnel syndrome a clinical neurophysiological study
Journal of The Peripheral Nervous System, 2007Co-Authors: Giampietro Zanette, Silvia Marani, Stefano TamburinAbstract:Patients with carpal tunnel syndrome (CTS) usually complain of pain and Paresthesia in the Hand or wrist, but pain proximally to the wrist has been frequently reported in this condition. This study was aimed at understanding which clinical features are associated with the presence of proximal pain (PP) in the upper limb of CTS patients. We recruited 250 patients with clinical and neurophysiological evidence of CTS. After thorough selection to rule out concomitant upper limb painful conditions, 112 patients (175 Hands) were included. PP was defined as the presence of pain in the upper limb proximally to the wrist (neck excluded) in association with sensory complaints in the Hand. Patients were asked about the presence and severity of proximal sensory complaints, the distribution of sensory complaints in the Hand, and underwent an objective evaluation and neurographic study. Thenar muscle strength was significantly larger, the neurophysiological measures were significantly less severe, and Hand Paresthesia was significantly greater in patients with PP. The neurographic score and the measures of median nerve damage were inversely correlated with the severity of PP. PP was related to extramedian spread of symptoms in the Hand. None of the objective/neurographic variables was related to severity of sensory complaints restricted to the Hand. PP may be found in a consistent number of CTS patients. PP may represent a clinical marker of mild median nerve damage. The presence of proximal complaints might be related to peripheral or central nervous system mechanisms.
